Funding Opportunity PAR-19-215 from the NIH Guide for Grants and Contracts. The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The over-arching goal of this NIBIB R25 program is to support educational activities that include innovative approaches to enhance biomedical engineering design education to ensure a future workforce that can meet the nations needs in biomedical research and healthcare technologies. To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on Courses for Skills Development. This FOA encourages applications from institutions that propose to establish new or to enhance existing team-based design courses or programs in undergraduate biomedical engineering departments or other degree-granting programs with biomedical engineering tracks/minors. This FOA targets undergraduate students. While current best practices such as multidisciplinary/interdisciplinary education, introduction to the regulatory pathway and other issues related to the commercialization of medical devices, and clinical immersion remain encouraged components of a strong BME program, this FOA also challenges institutions to propose other novel, innovative and/or ground-breaking activities that can form the basis of the next generation of biomedical engineering design education.

Competitive: Boston University MCB Dept.: The Department of Molecular and Cell Biology at the Boston University Henry M. Goldman School of Dental Medicine has an open faculty position at th... Boston, Massachusetts (US)

Notice NOT-HD-19-008 from the NIH Guide for Grants and Contracts

Notice NOT-HD-19-007 from the NIH Guide for Grants and Contracts

Notice NOT-RM-19-003 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-19-214 from the NIH Guide for Grants and Contracts. The overall goal of this initiative is to identify neurophysiological measures potential assays for treatment development research. The funding opportunity announcement (FOA) will support efforts to optimize and evaluate measures of neurophysiological processes that are disrupted within or across mental disorders in both healthy humans and in another species relevant to the therapeutic development pipeline. The initiative will support initial proof of concept studies aimed at identifying measures for potential development as preclinical assays for evaluating potential new drug and device therapies and their targets. Data will also reveal assay measures where the performance between preclinical animal species and humans is dissimilar, thus establishing a firm basis for limiting speculative extrapolations of preclinical animal findings to humans. The ultimate practical goal of this FOA is to improve the efficiency of the therapeutic development process by identifying coherence of measures and inconsistencies between the preclinical screening pipeline and clinical evaluation of new treatment candidates and thereby hasten the development of more effective treatments for mental disorders.

Competitive Salary: EMBL: Postdoctoral fellow Location: EM Cambridge, Cambridgeshire, England

Funding Opportunity RFA-DK-19-501 from the NIH Guide for Grants and Contracts. The Chronic Kidney Disease Biomarkers Consortium [CKD BioCon] was established in September 2009 as a result of RFA-DK-08-015 [Chronic Kidney Disease Biomarker Discovery and Validation Consortium (U01)] to develop, validate and qualify biomarkers based on existing biosamples from well-characterized CKD patients with longitudinal follow-up. The second phase of the CKD BioCon was funded in September 2014, pursuant to RFA DK-14-011. Two additional Centers were brought into the Consortium in 2015. The CKD BioCon currently consists of eight Participating Clinical Centers (PCCs) and is actively engaged in multiple research protocols. The DCC's goalover the next two years will enhance biomarker research in CKD by a) providing ongoing logistical support, expertise and statistical support to consortial work involving one or more PCCs, b) supervising the proposal, approval and progress of consortial studies, and supporting the conduct of the studies, and c) supervising transfer of data and samples between members of the consortium and repository activities of the consortium, as well as the NIDDK repository.

A Blue Gene/L and 3 racks of Linux GPU supercomputers for computational biology and bioinformatics; The Institute’s research success has resulted in a second...
From University of Minnesota - Thu, 07 Mar 2019 23:57:51 GMT - View all Minneapolis, MN jobs

A Blue Gene/L and 3 racks of Linux GPU supercomputers for computational biology and bioinformatics; The Institute’s research success has resulted in a second...
From University of Minnesota - Thu, 07 Mar 2019 23:57:51 GMT - View all Job, WV jobs

Salary in region of £17,489 per annum plus benefits: Wellcome Sanger Institute: Job Reference 83388 Bioinformatics Apprentice - IT (4 years) Salary in region of £17,489 per annum plus benefits Apprentice FTC 4 Years  We are Hinxton, Cambridgeshire, England

Funding Opportunity PAR-19-212 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, treatment optimization, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities; (2) drug abuse treatment and adherence interventions; (3) drug abuse treatment and adherence interventions that utilize technologies to boost effects and increase implementability and sustainability; (4) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (5) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (6) interventions to treat substance misuse and chronic pain. Research of interest includes but is not limited to Stage II and Stage III efficacy research.

Funding Opportunity PAR-19-213 from the NIH Guide for Grants and Contracts. The purpose of this funding opportunity announcement (FOA) is to encourage behavioral intervention development research to test efficacy, conduct clinical trials, examine mechanisms of behavior change, determine dose-response, treatment optimization, and/or ascertain best sequencing of behavioral, combined, sequential, or integrated behavioral and pharmacological (1) drug abuse treatment interventions, including interventions for patients with comorbidities; (2) drug abuse treatment and adherence interventions; (3) drug abuse treatment and adherence interventions that utilize technologies to boost effects and increase implementability and sustainability; (4) interventions to prevent the acquisition or transmission of HIV infection among individuals in drug abuse treatment; (5) interventions to promote adherence to drug abuse treatment, HIV and addiction medications; and (6) interventions to treat substance misuse and chronic pain. Research of interest includes but is not limited to Stage I research.

Notice NOT-NS-19-042 from the NIH Guide for Grants and Contracts

Notice NOT-NS-19-040 from the NIH Guide for Grants and Contracts

Salary in region of £17,489 per annum plus benefits: Wellcome Sanger Institute: Job Reference 83388 Bioinformatics Apprentice - IT (4 years) Salary in region of £17,489 per annum plus benefits Apprentice FTC 4 Years  We are Hinxton, Cambridgeshire, England

5 racks of Linux GPU supercomputers for computational biology and bioinformatics; The Institute’s research success has resulted in a second major expansion of...
From University of Minnesota - Wed, 06 Mar 2019 17:58:10 GMT - View all Minneapolis, MN jobs

5 racks of Linux GPU supercomputers for computational biology and bioinformatics; 2-3 years of experience in Cryo-EM including handling samples, using...
From University of Minnesota - Wed, 06 Mar 2019 17:58:10 GMT - View all Job, WV jobs

Funding Opportunity PAR-19-211 from the NIH Guide for Grants and Contracts. The purpose of this FOA is to provide support for institutional research training programs in areas relevant to the NINDS mission. These institutional research training programs should produce well-trained neuroscientists who leave the program with the research skills and scientific knowledge to make a significant contribution to neuroscience research. Programs should be designed to enhance the breadth and depth of training in NINDS mission areas by incorporating didactic, research and career development components in the context of a defined scientific theme. Programs may support basic, clinical and/or translational research. Critical components of programs supported by this FOA include mechanisms to ensure a thorough understanding of experimental design, strong statistics and analytical skills, and skills for communicating science, both orally and in writing, to a wide variety of audiences. Regardless of theme, programs should provide opportunities and activities that will foster the development of quantitative literacy and the application of quantitative approaches to the trainees' research. NINDS institutional training programs are intended to be 1-2 years in duration and support training of one or more of the following groups: dissertation stage predoctoral students in their 3rd and/or 4th year of graduate school, postdoctoral fellows and fellowship-stage clinicians. (NINDS does not support first or second year graduate students under this PAR).

Notice NOT-TR-19-018 from the NIH Guide for Grants and Contracts